Alaa Halawa
DirectoratNeumora Therapeutics· In proxies 2023–2025
Alaa Halawa sits on 5 public boards.
Boards1
- Neumora TherapeuticsDirector · 1 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
'%20fill='%235DDB77'%3e%3cg%20id='Group-11'%20transform='translate(581.000000,%20280.500000)'%3e%3cpath%20d='M138.49874,109.5%20C133.466774,109.5%20128.434809,107.983805%20124.144154,104.950056%20L84.5280975,76.9643007%20C79.7048373,73.5582961%2078.5542478,66.8753537%2081.9518071,62.0401042%20C85.3453007,57.2089306%2092.0116725,56.0486881%2096.8389984,59.4574099%20L136.449634,87.4445239%20C137.674761,88.308592%20139.318654,88.308592%20140.550557,87.4445239%20L180.162547,59.4574099%20C184.974966,56.0514053%20191.644048,57.2021376%20195.052449,62.0401042%20C198.445943,66.8753537%20197.291287,73.5582961%20192.472093,76.9643007%20L152.857392,104.950056%20C148.558605,107.983805%20143.530705,109.5%20138.49874,109.5'%20id='Fill-1'/%3e%3cpath%20d='M138.970865,172.5%20C133.91435,172.5%20128.860554,170.9738%20124.547963,167.928218%20L52.544975,117.037143%20C47.7047009,113.617854%2046.5486927,106.908846%2049.9582368,102.054738%20C53.3677808,97.2047212%2060.0644681,96.0454091%2064.8979422,99.4619702%20L136.894131,150.35441%20C138.133099,151.228668%20139.815431,151.221848%20141.0544,150.347591%20L213.110429,99.4578785%20C217.933023,96.0454091%20224.63923,97.207449%20228.046054,102.058829%20C231.451518,106.912938%20230.29279,113.621945%20225.448436,117.03987%20L153.393767,167.928218%20C149.081177,170.9738%20144.023301,172.5%20138.970865,172.5'%20id='Fill-3'/%3e%3cpath%20d='M91.7065769,265.5%20C86.1958012,265.5%2080.6823087,264.197037%2075.5790343,261.578831%20C24.7024984,235.448622%20-4.72045292,181.542786%200.621888968,124.235602%20C6.3662988,62.6566097%2052.7576038,11.8437763%20113.441337,0.669673594%20C119.294414,-0.369968193%20124.839148,3.47343196%20125.905443,9.31016105%20C126.971738,15.1523476%20123.120851,20.7571356%20117.30445,21.8281576%20C66.0095457,31.2708883%2026.7970551,74.2086399%2021.9464314,126.238482%20C17.4218087,174.722354%2042.3038374,220.332885%2085.3291818,242.421862%20C89.7899625,244.719443%2094.8715036,244.480681%2099.2698008,241.791528%20C103.850115,238.97822%20106.585807,234.11155%20106.585807,228.768719%20C106.585807,222.929261%20103.749598,217.433622%2098.9954166,214.065019%20L56.7416081,184.145984%20C51.9072844,180.729628%2050.7526975,174.014251%2054.1580499,169.163954%20C57.570194,164.31775%2064.2491401,163.141672%2069.0793887,166.571671%20L111.333197,196.490707%20C121.767947,203.877348%20128,215.942377%20128,228.768719%20C128,241.657821%20121.437871,253.387218%20110.444845,260.143525%20C104.644743,263.70041%2098.176339,265.5%2091.7065769,265.5'%20id='Fill-5'/%3e%3cpath%20d='M186.198096,265.5%20C179.652557,265.5%20173.135541,263.705993%20167.294948,260.138459%20C156.468118,253.511283%20150,241.943078%20150,229.18433%20C150,216.130677%20156.336365,203.841593%20166.952662,196.322875%20L208.922079,166.594787%20C213.745323,163.169244%20220.430765,164.331116%20223.838683,169.187496%20C227.24796,174.04251%20226.090707,180.762527%20221.259314,184.179878%20L179.291255,213.917522%20C174.355274,217.412696%20171.413245,223.116928%20171.413245,229.18433%20C171.413245,234.446204%20173.97224,239.021332%20178.426032,241.74784%20C182.949096,244.507115%20188.477286,244.690066%20193.24484,242.209312%20C232.315693,221.855389%20256.586755,181.785138%20256.586755,137.63673%20C256.586755,80.8551824%20216.25542,32.1589534%20160.685569,21.8495575%20C154.8735,20.7696035%20151.032291,15.158212%20152.10533,9.31062323%20C153.171578,3.46030385%20158.782623,-0.400770408%20164.575676,0.681914136%20C230.301368,12.8740616%20278,70.4706949%20278,137.63673%20C278,189.856804%20249.295521,237.24917%20203.095069,261.323541%20C197.733947,264.111488%20191.955835,265.5%20186.198096,265.5'%20id='Fill-8'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Board seats come from each company's latest proxy statement.
Experience
- Neumora TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -98%
- Alloy TherapeuticsPublic company · 4 yr
- Director2022 – Present · 4 yrNo stock prices for these years
- Pretzel TherapeuticsPublic company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- SynapticsPublic company · 2 yr
- Director2015 – 2017 · 2 yrNo stock prices for these years
- GlobalFoundriesPublic company · 1 yr
- Director2014 – 2015 · 1 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?